SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-24-003994
Filing Date
2024-12-17
Accepted
2024-12-17 07:08:22
Documents
16
Period of Report
2024-12-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2432469.htm   iXBRL 8-K 49261
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 10560
7 image00002.jpg GRAPHIC 23549
  Complete submission text file 0001178913-24-003994.txt   278940

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA slxn-20241217.xsd EX-101.SCH 4741
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxn-20241217_def.xml EX-101.DEF 18264
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxn-20241217_lab.xml EX-101.LAB 27749
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxn-20241217_pre.xml EX-101.PRE 20506
19 EXTRACTED XBRL INSTANCE DOCUMENT zk2432469_htm.xml XML 6552
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42253 | Film No.: 241553642
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)